Implementation of the national standardized german medication plan to detect drug related problems: results from the metropolmediplan2016 – mmp16

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: ABBAS, Zahra (Friedrich-Alexander-University Erlangen-Nuremberg, Molecular and Clinical Pharmacy, Erlangen, Germany)
  • Co-author(s): Zahra Abbas: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
    Simone Schächtele: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Susanne Schuster: Department of Emergency Medicine , Hospital Fürth, Fürth, Germany
    Martin Sedlmayr: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
    Frank Dörje: Erlangen University Hospital, Erlangen, Germany
    H. U. Prokosch: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
    Harald Dormann: Department of Emergency Medicine, Hospital Fürth, Fürth, Germany
    Martin Fromm: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Renke Maas: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
    Kristina Friedland: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
  • Abstract:

    Background

    A statutory entitlement to a standardized medication plan was established in October 2016 in Germany for all patients, prescribed at least three drugs. is available to FIP members and to congress participants of that specific congress. Please login